Menu
ÚHKT

Ing. Ota Fuchs, CSc.

odborný pracovník v laboratorních metodách

Tel: +420 221 977 512
Email: Ota.Fuchs@uhkt.cz

Pracoviště:

Impaktované publikace

[21]

Vyoral, D.; Babušiak, M.; Fuchs, O.; Petrák, J.

Native electrophoretic separation and femtomolar detection of 65Zn-containing proteins by storage phosphorimaging

[rok vydání 2006, impact factor 1.611]

[22]

Šárová, I.; Březinová, J.; Zemanová, Z.; Lizcová, L.; Berková, A.; Izáková, S.; Malinová, E.; Fuchs, O.; Kostečka, A.; Provazníková, D.; Filkuková, J.; Maaloufová, J.; Starý, J.; Michalová, K.

A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia

[rok vydání 2009, impact factor 1.537]

[23]

Grebeňová, D.; Cajthamlová, H.; Bartošová, J.; Marinov, I.; Klamová, H.; Fuchs, O.; Hrkal, Z.

Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin IX

[rok vydání 2006, impact factor 1.365]

[24]

Lemež, P.; Klamová, H.; Zemanová, Z.; Marinov, I.; Fuchs, O.; Schwarz, J.; Březinová, J.; Provazníková, D.; Kostečka, A.; Marková, J.; Michalová, K.; Jelínek, J.

Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia M0 without erythroblastic and megakaryocytic dysplasia

[rok vydání 2011, impact factor 1.354 ]

[25]

Fuchs, O.; Kostečka, A.; Provazníková, D.; Krásná, B.; Kotlín, R.; Staňková, M.; Kobylka, P.; Dostálová, G.; Zeman, M.; Chochola, M.

CCAAT/Enhancer-Binding Protein Alpha (CEBPA) polymorphisms and mutation in healthy individuals and in patients with peripheral artery disease, ischaemic heart disease and hyperlipidaemia

[rok vydání 2010, impact factor 0.729]

[26]

Fuchs, O.

Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias

[rok vydání 2008, impact factor 0.596]

[27]

Fuchs, O.

Inhibition of TGF-beta signaling for the treatment of tumor metastasis and fibrotic diseases

[rok vydání 2011, impact factor 0.500 ]

[28]

Fuchs, O.

Promising activity of mammalian target of rapamycin inhibitors in hematologic malignancies therapy

[rok vydání 2011, impact factor 0.500 ]

[29]

Fuchs, O.; Poňka, P.

The role of iron supply in the regulation of 5-aminolevulinate synthase mRNA levels in murine erythroleukemia cells

[rok vydání 2006, impact factor 0.420]

[30]

Fuchs, O.

Iron-responsive element-binding protein mRNA levels during erythroid differentiation of murine erythroleukemia cells

[rok vydání 2006, impact factor 0.418]

[31]

Fuchs, O.

Effects of intracellular chelatable iron and oxidative stress on transcription of classical cellular glutathione peroxidase gene in murine erythroleukemia cells

[rok vydání 2006, impact factor 0.385]

[32]

Fuchs, O.; Bokorova, R.

Rationale of targeting protein cereblon as a potential strategy for cancer treatment

[rok vydání 2020, impact factor 0.073 ]